Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Pascoe, Abigail C ^a,b   Sundar, Santhanam ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Castrate refractory; Prostate cancer; Prostate radiation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASTRATION; CLINICAL ARTICLE; GLEASON SCORE; HUMAN; MALE; METASTASIS; MICROMETASTASIS; MONOTHERAPY; PROSTATE CANCER; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT RESPONSE; BLOOD; DISEASE FREE SURVIVAL; DRUG RESISTANCE; METHODOLOGY; MORTALITY; PROSTATE TUMOR; RECURRENT DISEASE; SALVAGE THERAPY;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CASTRATION; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 84858721243     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-43     Document Type: Article

References (8)

1. Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R, Gospodarowicz M, Sanders K, Kostashuk E, Swanson G, Barber J, Hiltz A, Parmar MK, Sathya J, Anderson J, Hayter C, Hetherington J, Sydes MR, Parulekar W, . NCIC CTG PR.3/MRC UK PR07 investigators Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011, 378:2104-2111. 10.1016/S0140-6736(11)61095-7, 3243932, 22056152, NCIC CTG PR.3/MRC UK PR07 investigators.
2. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD, . Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3 Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer: an open randomised phase III trial. Lancet 2009, 373:301-308. 10.1016/S0140-6736(08)61815-2, 19091394, Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3.
3. Kawakami J, Cowan JE, Elkin EP, Latini DM, Duchane J, Carroll PR. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer 2006, 106:1708-1714. 10.1002/cncr.21799, 16544313.
4. Studer UE, Whelan P, Albrecht W, Casselman J, de Reijke T, Hauri D, Loidl W, Isorna S, Sundaram SK, Debois M, Collette L. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol 2006, 24:1868-1876. 10.1200/JCO.2005.04.7423, 16622261.
5. Sasaki T, Nakamura K, Ogawa K, Onishi H, Okamoto A, Koizumi M, Shioyama Y, Mitsumori M, Teshima T, . Japanese Patterns of Care Study Working Subgroup on Prostate Cancer Radiotherapy for patients with localized hormone refractory prostate cancer: results of the Patterns of Care Study in Japan. BJU Int 2009, 104:1462-1466. 10.1111/j.1464-410X.2009.08616.x, 19522869, Japanese Patterns of Care Study Working Subgroup on Prostate Cancer.
6. Oefelein M, Agarwal P, Resnick M. Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J Urol 2004, 171:1525-1528. 10.1097/01.ju.0000118294.88852.cd, 15017212.
7. Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006, 65:965-974. 10.1016/j.ijrobp.2006.04.029, 16798415.
8. Weckermann D, Polzer B, Ragg T, Blana A, Schlimok G, Arnholdt H, Bertz S, Harzmann R, Klein CA. Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. J Clin Oncol 2009, 27:1549-1556. 10.1200/JCO.2008.17.0563, 19237635.